O’Connor joins TG Therapeutics as CSO; plus changes at FogPharma, Gemini, Dicerna, Akcea and more

Cancer and autoimmune company TG Therapeutics Inc. (NASDAQ:TGTX) hired Owen O’Connor as CSO. He was director of the Center for Lymphoid Malignancies

Read the full 226 word article

How to gain access

Continue reading with a
two-week free trial.